ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA

ExoGMPâ„¢ is the world’s largest exosome manufacturing facility in Osong, South Korea. Cellosomeâ„¢ HA fillers are expected to be approved in 2023. ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ –…